SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 246 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $993,000 | -29.3% | 41,827 | -18.2% | 0.13% | -68.6% |
| Q3 2019 | $1,405,000 | -17.1% | 51,143 | -0.1% | 0.40% | -17.7% |
| Q2 2019 | $1,694,000 | -5.5% | 51,183 | +0.0% | 0.49% | -9.7% |
| Q1 2019 | $1,793,000 | +123.3% | 51,171 | +111.6% | 0.54% | +92.6% |
| Q4 2018 | $803,000 | -23.2% | 24,182 | +16.5% | 0.28% | -55.7% |
| Q3 2018 | $1,045,000 | -15.8% | 20,750 | 0.0% | 0.64% | +48.6% |
| Q2 2018 | $1,241,000 | +80.6% | 20,750 | +38.3% | 0.43% | +73.4% |
| Q1 2018 | $687,000 | +14.9% | 15,000 | 0.0% | 0.25% | +15.3% |
| Q4 2017 | $598,000 | – | 15,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |